RBM15 and cancer: By univariate survival analysis, we found that RBM15 expression was associated with patients’ OS in 10 cancer types, including ACC, KICH, KIRC, LGG, LIHC, PAAD, READ, STAD, THCA and THYM (Figure 3A).In addition, Kaplan-Meier OS curves showed that increased RBM15 expression was correlated with poor prognosis in 6 cancer types including ACC (p = 0.00039, HR = 1.23), KICH (p = 0.0065, HR = 1.37), LGG (p < 0.0001, HR = 1.15), LIHC (p = 0.00011, HR = 1.1), PAAD (p = 0.019, HR = 1.09) and THCA (p = 0.0057, HR = 1.35).